Results 131 to 140 of about 20,666 (164)

VCPIP1 drives diabetic cardiomyopathy by deubiquitinating AMPKγ1 and preventing AMPKα-γ subunit assembly in cardiomyocytes. [PDF]

Signal Transduct Target Ther
Han X, Huang Z, Liu G, Liu Y, Li W, Zheng J, Tong J, He M, Wu Y, Li Z, Luo W, Shi Q, Ying H, Liang G.   +13 more
europepmc   +1 more source

Emerging regulatory model of Ubiquitin-Specific Proteases 14 in cancer: from canonical oncogenesis to TME modulation, therapeutic resistance, and non-canonical activities. [PDF]

J Transl Med
Wang R, Yan F, Duan F, Xia W, Wang W, Wang Z, Sun F, Yu C, Zhang H, Yang L.   +9 more
europepmc   +1 more source

TTC26 scaffolds MINDY3-mediated RACK1 deubiquitination to drive osteoclastogenesis and pathological bone resorption. [PDF]

J Orthop Translat
Gao Y, Lai B, Yan R, He J, Lu T, Yang S, Chen J, Gao R, Jiang H, Zhou X.   +9 more
europepmc   +1 more source

USP5 in cancer: a therapeutic window into metabolism and drug resistance. [PDF]

J Transl Med
Li H, Wang H, Hu T.
europepmc   +1 more source

USP5 promotes glycolysis in cervical cancer by stabilizing FOXM1. [PDF]

Am J Cancer Res
Su L, Chen R, He T, Su X, Wu C, Wei X.
europepmc   +1 more source

Dual Roles of Ubiquitin-Specific Peptidase 10 (USP10) in Cancer. [PDF]

Cells
Zhai Y, Zhou L, Zhao M, Lin Q.
europepmc   +1 more source

Dauriporphine Suppresses Cell Proliferation, Metastasis, and Stemness of Non-Small Cell Lung Cancer Through the Regulation of the USP7/CASK. [PDF]

Drug Dev Res
Hou P, Wu Q.
europepmc   +1 more source

USP44 Stabilizes MAOB via Deubiquitination to Inhibit Cisplatin Resistance in Lung Adenocarcinoma. [PDF]

Int J Genomics
Liang Z, Zhang H, Jiang J, Li C, Yuan F.
europepmc   +1 more source

PFKFB4 Deubiquitination by USP10 Enhances Fumarate Metabolism to Orchestrate the KDM1A/Rad51 Axis and Confer Radioresistance in Lung Cancer. [PDF]

Adv Sci (Weinh)
Chen Y, Wu Z, Yang Y, Fang R, Xue H, Zhou R, Wu G, Jie X.   +7 more
europepmc   +1 more source

Cardiomyocyte-enriched OTUD5 alleviates septic cardiomyopathy by promoting NLRP3 deubiquitination and inhibiting NLRP3 inflammasome activation. [PDF]

Clin Transl Med
Jiang Y, Jia Z, Zheng Z, Liao Y, Zhao Q, Lin W, Xu D, Zhang N, Liang G, Ye B.   +9 more
europepmc   +1 more source